Article
Specific mutations in KRAS codon 12 are associated with worse overall survival in patients with advanced and recurrent colorectal cancer.
British journal of cancer - 28 Mar 2017
Jones Robert P, Sutton Paul A, Evans Jonathan P, Clifford Rachel, McAvoy Andrew, Lewis James, Rousseau Abigail, Mountford Roger, McWhirter Derek, Malik Hassan Z
Abstract excerpt
BACKGROUND: Activating mutations in KRAS have been suggested as potential predictive and prognostic biomarkers. However, the prognostic impact of specific point mutations remains less clear. This study assessed the prognostic impact of specific KRAS mutations on survival for patients with colorectal cancer. METHODS: Retrospective review of patients KRAS typed for advanced and recurrent colorectal cancer between...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
